Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2
SARS-CoV-2의 삼중 돌연변이 변이체에 대한 타미바로텐의 전산 용도 변경
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
adaptive
alteration
Antiviral
antiviral therapy
Brazil
Corona
coronavirus disease
Coronavirus-2
country
COVID-19
Delta
delta variant
develop
drug
drug candidate
drug repositioning
Drug repurposing
Drug-resistance
effective
followed by
functional
genomic
global pandemic
high mortality rate
Host
increase
ineffectiveness
inhibitor
Ligand
molecular
molecular docking
molecular dynamics
mutant
Mutation
outbreak
pathogenic
Proteins
reported
Research
resistance
responsible
Safe
safety profile
SARS-CoV-2
second wave
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
South Africa
Spike protein
structural proteins
tamibarotene
Tamibarotene.
therapy
variant of SARS-CoV-2
viral spike protein
viral strain
Virtual screening
virulent
was performed
was selected
[DOI] 10.1016/j.compbiomed.2021.104748 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.compbiomed.2021.104748 PMC 바로가기 [Article Type] Article